Cholinergic dysfunction in diseases with LEWY bodies

Neurology

Volumn 54, Issue 2, 2000, Pages 407-411

  Tiraboschi, P ^a   Hansen, L A ^b   Alford, M ^b   Sabbagh, M N ^b,c   Schoos, B ^c   Masliah, E ^b   Thal, L J ^b,c   Corey Bloom, Jody ^b,c  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

AD; APOE; Cholinergic dysfunction; Lewy body disease

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE ACETYLTRANSFERASE;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENOTYPE; HUMAN; HUMAN TISSUE; LEWY BODY; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0034711764     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.2.407     Document Type: Article

References (40)

1. Davies P, Maloney AJF. Selective loss of cholinergic neurons in Alzheimer's disease. Lancet 1976;2:1403.
2. Perry EK, Marshall E, Perry RH, et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 1990;4:87-95.
3. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993; 43:1927-1934.
4. Perry EK, Irving D, Kerwin JM, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer's disease. Alzheimer Dis Assoc Disord 1993;7:69-79.
5. Dickson DW, Davies P, Mayeux R, et al. Diffuse Lewy body disease: neuropathological and biochemical studies of six patients. Acta Neuropathol 1987;75:8-15.
6. Samuel W, Alford M, Hofstetter R, Hansen L. Dementia with Lewy bodies versus pure Alzheimer's disease: differences in cognition, neuropathology, cholinergic dysfunction and synapse density. J Neuropathol Exp Neurol 1997;56:499-508.
7. Whitehouse PJ, Price DL, Clark AW, et al. Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122-126.
8. Perry EK, Curtis M, Dick DJ, et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985;48:413-421.
9. Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978;2:1457-1459.
10. Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci 1983;57:407-417.
11. Perry R, McKeith I, Perry E. Lewy body dementia-clinical pathological and neurochemical interconnections. J Neural Transm 1997;51(suppl):95-109.
12. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop. Neurology 1996;47:1113-1124.
13. Salmon DP, Galasko D. Neuropsychological aspects of Lewy body dementia. In: Perry EK, Perry RH, McKeith I, eds. Lewy body dementia. New York: Cambridge University Press, 1996: 99-113.
14. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ∈4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1951.
15. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994;145:1472-1484.
16. Poirier J, Delisle MC, Quirion R, et al. Apolipoprotein ∈4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 1995;92:12260-12264.
17. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
18. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd edition, revised. Washington, DC: American Psychiatric Association, 1987.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
22. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:132-144.
23. Terry RD, Peck A, DeTeresa R, Schecter R, Horoupian DS. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981;10:184-192.
24. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:44-52.
25. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
26. Wenham PR, Price WM, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
27. Fonnum F. A rapid radiochemical method of determination of choline acetyltransferase. J Neurochem 1975;24:407-409.
28. Hansen LA, DeTeresa R, Tobias H, Alford M, Terry RD. Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol 1988;131:507-518.
29. Gibb WRG, Mountjoy CQ, Mann DMA, Lees AJ. A pathological study of the association between Lewy body disease and Alzheimer's disease. J Neurol Neurosurg Psychiatry 1989;52: 701-708.
30. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J 1984;288:961-964.
31. Hansen LA. The Lewy body variant of Alzheimer disease. J Neural Transm 1997;51(suppl):83-93.
32. Gearing M, Lynn M, Mirra S. Neurofibrillary pathology in Alzheimer disease with Lewy bodies. Arch Neurol 1999;56: 203-208.
33. Heyman A, Fillenbaum GG, Gearing M. Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease. Consortium to Establish a Registry for Alzheimer's Disease, Part XIX. Neurology 1999;52:1839-1844.
34. Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. Cognitive profile of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol 1998;55:994-1000.
35. Paulus W, Jellinger K. The neuropathologic basis of different types of Parkinson's disease. J Neuropathol Exp Neurol 1991; 50:743-755.
36. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathological study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-148.
37. Allen SJ, MacGowan SH, Tyler S, et al. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein ∈4 genotype. Neurosci Lett 1997;239:33-36.
38. Morris CM, Massey HM, Benjamin R, et al. Molecular biology of APOE alleles in Alzheimer's and non Alzheimer's dementias. J Neural Transm 1996;47(suppl):205-218.
39. Levy R, Eagger SA, Griffiths M, et al. Lewy bodies and response to tacrine in AD. Lancet 1994;343:176.
40. Cummings JL. Changes in neuropsychiatric symptoms as outcome measures in clinical trials with cholinergic therapies for Alzheimer's disease. Alzheimer Dis Assoc Disord 1997; 11(suppl 4):S1-9.